Drug intelligence / Profile preview

Terraflora

Development stage: Unknown
Lead developer: Enviromedica
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Terraflora is a soil-based synbiotic dietary supplement designed to support gastrointestinal health and microbial diversity. Developed by Enviromedica, it combines a blend of spore-forming probiotics, known as soil-based organisms (SBOs), with a prebiotic bio-complex derived from ancient food sources. The probiotic component consists of resilient *Bacillus* strains, such as *B. subtilis* and *B. coagulans*, which are naturally protected by a spore coating that allows them to survive the acidic environment of the stomach and reach the lower GI tract intact. The prebiotic component includes larch arabinogalactan and medicinal mushroom extracts (Reishi and Chaga) to provide selective nourishment for beneficial gut bacteria. By introducing these hardy microbes and supporting their growth, Terraflora aims to improve digestion, enhance immune function, and restore a healthy microbial balance in the gut.

Brand names: Terraflora
Other names: Terraflora Broad Spectrum Synbiotic

Beyond the preview

Go deeper on Terraflora.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terraflora.

Explore the full profile